Small Molecules
22 August 2013
Study of Novel Nanoliposomal Irinotecan (MM-398) in Late Stage Pancreatic Cancer Published in British Journal of Cancer22 August 2013
Navidea Biopharmaceuticals Announces Agreement with FDA on Special Protocol Assessments for NAV5001 Phase 3 Program21 August 2013
Catabasis Initiates Phase 2 Trial of CAT-2003 in Patients with Hypertriglyceridemia and Hypercholesterolemia21 August 2013
Arno Therapeutics Initiates Pharmacokinetic Study for Onapristone Following Regulatory Acceptance20 August 2013
RedHill Biopharma Announces Positive European Regulatory Meetings Regarding Its European Phase III Plan for RHB-104 (Crohn’s)20 August 2013
Oncopeptides Initiates Phase II Clinical Study with Melflufen in the Treatment of Multiple Myeloma Patients20 August 2013
Otonomy Announces Positive Phase 1b Results for OTO-201 in Pediatric Patients Undergoing Ear Tube Placement Surgery19 August 2013
Positive Results for D-Pharm’s Investigational Drugs in Models of Human African Trypanosomiasis and Malaria19 August 2013
Velocity Pharmaceutical Development and Tigercat Pharma Inc. Announce Submission of IND Application for VPD-73715 August 2013
Forest Laboratories and Almirall Decide to Delay NDA Filing for Aclidinium/formoterol Combination14 August 2013
Chimerix Announces Top Line Data From CMX001 Phase 2 Adenovirus Study and Late-Breaker Presentation at ICAACNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports